SCHEMBL8485128

SCHEMBL8485128

COc1ccc(C=NNc2nc(N)nc3[nH]cnc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
HPGD P15428 3/20 0.53
MAPT P10636 10/20 0.52
GAA P10253 5/20 0.52
LMNA P02545 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
RAB9A P51151 6/20 0.50
NPC1 O15118 5/20 0.50
PKM P14618 2/20 0.50
TP53 P04637 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HTT P42858 1/20 0.45
KDM4E B2RXH2 2/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8480596 0.86 MAPT (0.56) SMN1; SMN2HPGDMAPTGAALMNA
SCHEMBL30162651 0.78 BRAF (0.50) SMN1; SMN2MAPTGAARAB9ANPC1
SCHEMBL8826303 0.78 BRAF (0.50) SMN1; SMN2MAPTGAARAB9ANPC1
SCHEMBL8484282 0.77 XDH (0.51) SMN1; SMN2HPGDMAPTGAALMNA
SCHEMBL8485562 0.77 MAPT (0.48) SMN1; SMN2HPGDMAPTGAALMNA
SCHEMBL8826162 0.75 APP (0.56) MAPTKDM4EPOLB
SCHEMBL17560779 0.73 SMN1; SMN2 (0.85) SMN1; SMN2HPGDMAPTGAALMNA
SCHEMBL17560783 0.73 SMN1; SMN2 (0.85) SMN1; SMN2HPGDMAPTGAALMNA
SCHEMBL8481591 0.72 NPC1 (0.55) SMN1; SMN2HPGDMAPTGAACYP1A2
SCHEMBL8484763 0.70 RAB9A (0.53) SMN1; SMN2HPGDMAPTGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990118-A NOVEL PURINE COMPOUNDS AND TRIAZOLOPURINE COMPOUNDS WHICH INHIBIT XANTHINE OXIDASE; REMEDIES FOR HYPERURICEMIA, AND AS PREVENTIVE AND THERAPEUTIC AGENTS FOR GOUT YAMASA CORPORATION (JP) 1999-11-23 US disclosed
EP-0811624-A1 PURINE COMPOUNDS AND XANTHINE OXIDASE INHIBITORS YAMASA CORPORATION (JP) 1997-12-10 EP disclosed